NASDAQ:NUTX - Nasdaq - US67079U3068 - Common Stock - Currency: USD
NASDAQ:NUTX (2/21/2025, 8:00:01 PM)
57.6
-4.05 (-6.57%)
The current stock price of NUTX is 57.6 USD. In the past month the price increased by 40.63%. In the past year, price increased by 226.25%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 10.97 | 82.08B | ||
CVS | CVS HEALTH CORP | 11.71 | 79.88B | ||
LH | LABCORP HOLDINGS INC | 17.15 | 20.84B | ||
DGX | QUEST DIAGNOSTICS INC | 19.1 | 19.12B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 13.74 | 13.55B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 148.77 | 12.18B | ||
DVA | DAVITA INC | 14.99 | 11.68B | ||
HIMS | HIMS & HERS HEALTH INC | 112 | 10.77B | ||
CHE | CHEMED CORP | 23.84 | 8.18B | ||
CRVL | CORVEL CORP | 25.97 | 5.57B | ||
OPCH | OPTION CARE HEALTH INC | 26.89 | 5.45B | ||
GH | GUARDANT HEALTH INC | N/A | 5.30B |
Nutex Health Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Houston, Texas and currently employs 800 full-time employees. The company went IPO on 2011-03-18. Nutex Health Inc. is a healthcare management and operations company. The firm operates through three segments: The Hospital division, The Population Health Management (PHM) division and The Real Estate division. The Hospital division develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs) providing comprehensive and high-quality 24/7 care. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). The Real Estate division owns the land and hospital buildings which are leased to its hospital entities. The firm also provides limited services to one health maintenance organization (HMO) and two other IPAs in Southern and Northern California. The firm's cloud-based technology platform aggregates clinical and claims data across multiple settings, information systems, and sources to create a holistic view of patients and providers.
NUTEX HEALTH INC
6030 S. Rice Ave., Suite C
Houston TEXAS US
Employees: 800
Company Website: https://www.nutexhealth.com/
Investor Relations: https://www.nutexhealth.com/investors/
Phone: 17136600557
The current stock price of NUTX is 57.6 USD. The price decreased by -6.57% in the last trading session.
The exchange symbol of NUTEX HEALTH INC is NUTX and it is listed on the Nasdaq exchange.
NUTX stock is listed on the Nasdaq exchange.
9 analysts have analysed NUTX and the average price target is 56.44 USD. This implies a price decrease of -2.01% is expected in the next year compared to the current price of 57.6. Check the NUTEX HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
NUTEX HEALTH INC (NUTX) has a market capitalization of 313.34M USD. This makes NUTX a Small Cap stock.
NUTEX HEALTH INC (NUTX) currently has 800 employees.
NUTEX HEALTH INC (NUTX) has a support level at 36.59 and a resistance level at 66.07. Check the full technical report for a detailed analysis of NUTX support and resistance levels.
The Revenue of NUTEX HEALTH INC (NUTX) is expected to grow by 21.68% in the next year. Check the estimates tab for more information on the NUTX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NUTX does not pay a dividend.
NUTEX HEALTH INC (NUTX) will report earnings on 2025-03-26, after the market close.
NUTEX HEALTH INC (NUTX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.39).
The outstanding short interest for NUTEX HEALTH INC (NUTX) is 0.88% of its float. Check the ownership tab for more information on the NUTX short interest.
ChartMill assigns a technical rating of 10 / 10 to NUTX. When comparing the yearly performance of all stocks, NUTX is one of the better performing stocks in the market, outperforming 98.47% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to NUTX. NUTX has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months NUTX reported a non-GAAP Earnings per Share(EPS) of -2.39. The EPS increased by 68.13% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -9.38% | ||
ROE | -68.06% | ||
Debt/Equity | 4.49 |
ChartMill assigns a Buy % Consensus number of 82% to NUTX. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 54.14% and a revenue growth 21.68% for NUTX